Inhibitors of the chemokine receptor CxCR3

Details for Australian Patent Application No. 2009215643 (hide)

Owner Sanofi-Aventis

Inventors Thorpe, David S.; Smrcina, Martin; Cabel, Dagmar D.

Agent Watermark

Pub. Number AU-A-2009215643

PCT Pub. Number WO2009/105435

Priority 61/029,738 19.02.08 US

Filing date 18 February 2009

Wipo publication date 27 August 2009

International Classifications

C07D 295/033 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07D 471/20 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

9 September 2010 PCT application entered the National Phase

  PCT publication WO2009/105435 Priority application(s): WO2009/105435

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009215644-Method and system for loading of tubing into a pumping device

2009215636-Breastmilk handling apparatus particularly useful for warming of breastmilk containers such as bottles and syringes